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promotion of CuII binding in a wide pH range –
complementary potentiometric, spectroscopic and
electrochemical studies†
Łukasz Szyrwiel,*ab Jo´zsef S. Pap,*c Łukasz Szczukowski,b Zsolt Kerner,c
Justyna Brasun´,d Bartosz Setner,e Zbigniew Szewczuke and Wiesław Malinkab
Modiﬁcations in linear and cyclic peptides have been widely explored in relation with the associated eﬀects
on the coordination of CuII. Branching of peptides is yet another innovative conception to promote metal
binding. The three dimensional (3D), quasi-tripodal structure of the new ligand, H-His-Dap(H-His)-His-NH2
(3H, where Dap ¼ L-2,3-diaminopropionic acid), which is created by the vicinal two N-terminal and one
C-terminal functions of Dap allows triple-arm extension and oﬀers new options in metal binding. A
strategy is presented for the characterization of 3H focusing on the role of structural domains in CuII
binding by comparison of analogous tetrapeptides that involve a varying number of His and Gly residues.
Potentiometric, spectroscopic (UV-Vis, CD and EPR), mass spectrometric and electrochemical data
indicate that in monomeric CuII–3H complexes the metal is bound with higher aﬃnity compared to its
structural domains indicating that the eﬀect of 3D branching should be taken as an important factor for
future studies on CuII peptide constructs.Introduction
Applications of designed peptides as specic ligands for copper
have become expansive, including catalysts/electrocatalysts,1
peptide based uorescent metallo-probes,2 chelating agents in
neurodegenerative diseases3 and metal ion selective cell
organelle targeting probes.4 This advancement in applications
was largely promoted by the decades-long studies on copper–
peptide complexes triggered by their relevance to biological
systems.5 The number and position of certain residues in linear
peptides, especially of histidine, substantially inuences
stability, coordination sphere and nuclearity of the
complexes.5,6
Branching of peptides potentially improves the proteolytic
and serum stability,7,8 selective cell uptake properties,9 and also,c, 2, av. Pr. Angot, F-64053 Pau, France.
33-5594-07681; Tel: +33-5594-07739
w Medical University, ul. Borowska 211,
hemistry and Catalysis Department, PO
w Medical University, Borowska 211a, 50-
, ul. F. Joliot-Curie 14, 50-383 Wrocław,
ESI) available: Fig. S1–S4 and Table S1.
31the metal binding eﬃciency.3,10 The improved targeting proper-
ties of this peptide family, compared to linear ones, was applied
in gene transport processes, e.g., His-rich peptides.11 The
unique, three dimensional (3D) structure was also improved to
be more eﬀective in multiple antigen peptides (MAP),12 in anti-
bacterial13 and in some therapeutic14 agents. Expanding the eld
of new, triple-arm peptides and their metal complex engineering
can be crucial for the further development of those applications
as well as, new enzyme mimicking centers,15 some drugs,16
radiopharmaceutics17 or novel articial proteins.18,19
Peptide branching with lysine promotes formation of
dimeric complexes.3 In a recent study we demonstrated that
dimerization at physiological pH can be suppressed with Dap-
based branched peptides (Dap ¼ L-2,3-diaminopropionic
acid), H-Gly-Dap(H-Gly)-His-NH2 (2GH) H-His-Dap(H-His)-Gly-
NH2 (2HG) (Fig. 1 2HG, 2GH).10 Here we report a new branched
tetrapeptide that is also built on Dap and contains one
C-terminal and two N-terminal histidine residues (Fig. 1, 3H).
From our previous study we learnt that placement of one
histidine residue at the C-, or two at the N-terminal of Dap
inuences the CuII binding mode very diﬀerently. Here we
discuss how the simultaneous presence of both domains will
aﬀect CuII complex stabilization, paying special attention to
redox properties which may be of crucial importance, since
inside the living cells CuI can be oen stabilized. During the
design of Cu-based biomimetics and bioinspired pharma-
ceuticals and in-cell metal transporters it is thereforeThis journal is © The Royal Society of Chemistry 2015
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View Article Onlinedesirable to consider the redox behavior of these systems. In
addition, copper may occur in three oxidation states when
ligated and usually one of the two possible single electron
redox transitions, +3/+2 or +2/+1 between these states can be
observed in copper enzymes and complexes with articial
ligands. This leads to rich redox chemistry23 and catalysis,
especially using molecular oxygen,21 and, in connection, the
control of oxidative stress in living species.22
Electrochemical studies on copper complexes rarely go
beyond cyclic voltammetry (CV) performed either in an aprotic
solvent or in water at a xed pH.24–27 CV oﬀers a wealth of
experimental information and includes both kinetic and
thermodynamic details of many chemical systems; on the
other hand, pKa values that substantially control short range
proton transfer coupled to the electron transfer, and well
dened formal potentials are only accessible when E vs. pH
(Pourbaix) diagrams are considered.20,23 For this reason, aer
the initial CV experiments we also applied square-wave vol-
tammetry (SWV) to address the pH-dependence of the CuIII/II
transition and tted the data with a modied Nernst equation
in part relying on the speciation and spectroscopic
information.
Potentiometric, spectroscopic and mass spectrometry data
indicate eﬀect of N- and C-terminal cooperation in stabilization
of Cu binding. Results from electrochemistry also underline the
advantages of the simultaneous presence of histidine residues
on each arm of three branched peptides.
Experimental
Ligand synthesis
Materials. All Fmoc amino acids, including Fmoc-
L-Dap(Fmoc)-OH used as a branching amino acid, solvents andFig. 1 Graphical presentation of combining two 2,3-dia-
minopropionic branched peptides in one that contains both metal
binding histidine domains. The two N-terminal peptide arms are
marked with red and the C-terminal arm is marked with blue. 2HG ¼
H-His-Dap(H-His)-Gly-NH2, 2GH ¼ H-Gly-Dap(H-Gly)-His-NH2 and
3H ¼ H-His-Dap(H-His)-His-NH2 peptides.
This journal is © The Royal Society of Chemistry 2015reagents were purchased from Iris Biotech GmbH
(Marktredwitz, Germany) and used without further purication.
Peptide synthesis
The synthesis of the peptide H-His-Dap(H-His)-His-NH2 was
performed manually on the Rink Amide MBHA resin (loading:
0.52 mM g1) in a polypropylene syringe reactor (Intavis AG,
Ko¨ln, Germany) equipped with polyethylene lter, according to
the standard Fmoc (9-uorenylmethoxycarbonyl) solid phase
synthesis procedure. TBTU (O-(benzotriazol-1-yl)-N,N,N0,N0-tetra-
methyluronium tetrauoroborate) was used as a coupling reagent
(3 equivalents). Oxyma Pure (ethyl-2-cyano-2-(hydroxyimino)
acetate) (3 equivalents) and DIPEA (N,N-diisopropylethylamine)
(6 equivalents) were used as additives. DMF (N,N-dime-
thylformamide) was used as solvent. Each coupling step was
performed for 2 h. Aer removal of the Fmoc-protecting groups,
from the diaminopropionic acid derivative, attached to the resin,
with 25% piperidine in DMF, a mixture of Fmoc-His(Trt)-OH/
TBTU/Oxyma Pure/DIPEA (6 equivalents of each reagent) in
DMF was added and stirred for 24 h. The end of a coupling was
conrmed by the Kaiser test. The peptide was cleaved from the
resin simultaneously with the side chain deprotection using a
solution of TFA/H2O/TIS (95/2.5/2.5, v/v/v) at room temperature
for 2 h and puried by semi-preparative RP-HPLC.
Purication and mass spectrometry analysis
The peptide was puried by the RP-HPLC using a Varian ProStar
(Palo Alto, CA, California) with UV detection (210 nm and
280 nm) on a TSKgel ODS-120T 12TG08eh004 column (215 
30.0 mm, 10 mm) equipped with a TSKguard column ODS
(21,5  7.5 mm, 10 mm), with a gradient elution of 0–80% B in A
(A ¼ 0.1% TFA in water; B¼ 0.1% TFA in acetonitrile/H2O, 4 : 1)
for 40 min (ow rate 7 mL min1). The main peak, corre-
sponding to the peptide H-His-Dap(H-His)-His-NH2, was
collected and the fraction was lyophilized. All spectrometric
experiments for synthesis product identication were per-
formed on a Bruker micrOTOF-Q mass spectrometer (Bruker
Daltonics, Bremen, Germany) equipped with an ESI source.
Analyte solutions (1 mg in 1 mL of 50 : 50 acetonitrile–water
mixture containing 0.1% HCOOH) were pumped at a rate of
2 mL min1. The instrument was operated in the positive ion
mode and calibrated before each analysis with the Tunemix™
mixture (Agilent Technologies, Santa Clara, USA) in quadratic
method. For the MS spectra analysis, the Bruker Compass Data
Analysis 4.0 soware was used. Sophisticated Numerical
Annotation Procedure (SNAP) algorithm was used for nding
peaks. The measuredm/z for H-His-Dap(H-His)-His-NH2 (3H) of
[M + H+] ion was 515.2632 (calculated 515.2632).
Potentiometric studies
Peptide protonation and CuII complex stability constants were
calculated from three titration curves carried out over the pH
range 2.5–11.0 at 298 K under argon atmosphere. Ligand
concentration was set in a range of 1  103 to 1.5  103 M.
Metal-to-ligand ratio was 0.82 : 1, 0.85 : 1 and 0.95 : 1. The pH-
metric titrations were performed in 0.1 M KCl on a MetrohmRSC Adv., 2015, 5, 56922–56931 | 56923
Fig. 2 Speciation diagram for the system containing CuII and 3H, [CuII]
¼ 1  103 M, 1CuII : 1L (where L ¼ 3H).
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View Article Onlinetitrator using a Mettler Toledo InLab® Micro combined elec-
trode calibrated for hydrogen ion concentration using HCl. The
stability constants were calculated with HYPERQUAD 2013.28
Standard deviations quoted were computed with the same
soware and refer to random errors only.
Spectroscopic studies (UV-Vis, CD, EPR)
Absorption spectra of CuII complexes were recorded on a Per-
kinElmer Lambda 25 spectrophotometer in 1 and 0.5 cm path
length quartz cells. All UV-Vis spectra were collected in the
300–900 nm range. Circular dichroism (CD) spectra were
recorded on a JASCO J 750 spectropolarimeter in the 250–900
nm range, using 1 and 0.1 cm cuvettes. Spectroscopic
measurements were carried out at 298 K, at concentrations from
0.8 to 1.4  103 M and M : L ¼ 1 : 1. Electron paramagnetic
resonance (EPR) spectra were measured on a Bruker Elexsys 500
spectrometer operating at the X-band frequency (9.7 GHz) at
123 K using narrow quartz capillaries to reduce the dielectric
loss of the cavity. The ligand concentration was adjusted to 1 to
1.5  103 M in 30% (v/v) polyethylene glycol/water solution.
Data from X-band EPR spectroscopy have been extracted by
simulation of the experimental spectra taken at diﬀerent pH
values, at 123 K. For further details of the simulation method
see ref. 10.
Mass spectrometry measurements
High-resolution mass spectra were obtained on a Bruker micrQ-
FTMS spectrometer. Electrospray ionization (ESI-MS) mass
spectra were measured in the positive ion mode. Before each
run the instrument was calibrated externally with the
Tunemix™mixture. The ion source parameters were as follows:
dry gas – nitrogen, temperature 170 C, transfer time 120 ps,
collision voltage 1.0 eV. The sample was dissolved in aqueous
solution while the pH was adjusted with ammonium acetate to
pH 4.5 and 6.8. The peptide concentration was in the 105
to 104 M range. The solution was infused at a ow rate of
3 mLmin1. Simulations of the isotopic patterns were calculated
using Bruker Data Analysis 4.0 soware.
Electrochemistry
Cyclic voltammetry (CV), chronoamperometry (CA) and square-
wave voltammetry (SWV) measurements were performed on a
SP-150 potentiostat (BioLogic) equipped with a low-current unit.
A standard three-electrode setup was used including a glassy
carbon working electrode (GC, 0.072 cm2), Pt auxiliary electrode
(2 cm2) and Ag/AgCl (3 M KCl) reference electrode. The cell
was modied to accommodate a pH microelectrode (Mettler-
Toledo). The working electrode was carefully rinsed, polished
and rinsed again right before each measurement (note that
unpolished GC electrodes provide biased results, especially with
peptides, for further information see ref. 29 and 30). The cell
was kept under argon throughout the measurements, the O2
level was checked with an optical O2 sensor (Ocean Optics
NeoFox). SWV settings were: 0.73 mM Cu–3H, 100 mM NaClO4
electrolyte, 25 C, pulse width 10 ms (f ¼ 50 Hz), step potential
0.2 mV, SW pulse height 25 mV. The raw current curves (net56924 | RSC Adv., 2015, 5, 56922–56931current, Inet ¼ forward minus reverse current, Ifor  Irev) were
baseline corrected uniformly with tted cubic baselines to
obtain the curves plotted in Fig. 7. All salts were purchased from
commercial sources and were of puriss p.a. grade.Results and discussion
Potentiometric titration, ESI-MS and pH-dependence of
UV-Vis, CD and EPR spectroscopy
Complex formation between 3H and CuII in a 1 : 1 solution
starts already at acidic pH and increasing the pH to 3.5 results
in a dominant CuH3L complex (Fig. 2 and Table 1). The
observed UV-Vis parameters for this species are close to those
where CuII is bound with {2Nim} donors.31 This nding is in
good agreement with analysis of potentiometric data, since the
log KCuL* ¼ log bCuH3L  log bH3L ¼ 6.21(1) is close to log K*CuL
of complexes with {2Nim} proposed in the literature (log b* ¼
6.4 (ref. 32) or 6.48 (ref. 31)).
X-band EPR spectroscopic results (Table 2 and Fig. 3)
support this speciation, indicating the presence of two addi-
tional species to Cuaq
II up to pH4.5 (Fig. 2). It is apparent from
the experimental X-band EPR spectra that these S ¼ 1/2 species
give axial signal with gk > gt > 2.0, but lower than g-values for
Cuaq
II. The characteristic ACuk [ A
Cu
t splitting pattern is typical
for dx2y2 ground state.33 More precise g-tensors, hyperne (hf)
and superhyperne (shf) coupling parameters were extracted by
simulation of the spectra. The simulated component spectra for
the contributing species at a given pH were tted by optimali-
zation of the typical couplings of the unpaired electron to the
63Cu and 65Cu nuclei (I ¼ 3/2). Shf coupling to nitrogen nuclei
(14N, I ¼ 1) can be expected for the copper–peptide complexes.
Although the shf couplings to diﬀerent numbers of equal
nitrogen nuclei (Table 2) in the equatorial positions at lower pH
remain unresolved, they still contribute to the improvement of
the ttings. Rhombic anisotropy, e.g., splitting of gk to gx and gy,
at a varying level occurs in the investigated pH range (from 3 to
10) indicating distortion of the elongated octahedral (or square-This journal is © The Royal Society of Chemistry 2015
Table 1 The logarithms of the protonation constants (log bHxL) and
stability constants (log bCuHL) for Cu
II complexes with 3H, UV-Vis and
CD spectroscopic parameters for the respective species (T¼ 298 K, I¼
0.1 M KCl)
Species
Potentiometry UV-Vis CD
log b log K
(l [nm],
3 [M1 cm1])
(l [nm],
D3 [M1 cm1])
H5L 30.69(3) 4.47(2)
H4L 26.22(3) 5.28(2)
H3L 20.94(3) 6.17(2)
H2L 14.77(2) 6.99(2)
HL 7.78(3)
CuH3L 27.16(1) 670, 29
CuHL 19.51(1) 5.28(2) 538, 60 562, 0.37
487, 0.15
311, 0.45
272, sh
CuL 14.23(3) 6.29(2) 532, 91 562, 0.60
478, 0.21
311, 0.97
272, sh
CuH1L 7.95(3) 7.51(3) 530, 98 563, 0.61
478, 0.22
308, 1.23
271, sh
CuH2L 0.43(4) 528, 103 561, 0.64
480, 0.23
309, 1.24
271, sh
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View Article Onlinebased pyramid) geometry. In particular, the EPR parameters for
CuH3L corroborate other spectroscopic results. In the pH range
4.5–5.8 the CuHL and CuL species dominate (Fig. 2). The switch
between the 2GH and 2HG domains (Fig. 1), more specically
the histidine at the C-terminal arm of 2GH starts to play critical
role in CuII binding when pH is increased (Fig. 4 and S1†).
The ESI-MS results carried out at pH 6.8 conrmed the
exclusive occurrence of monomeric complex in case of Cu : L
molar ratios of 0.4 : 1.0 and 0.7 : 1.0 (Fig. 5). The observed Cu–L
signal pattern corresponds to two single charged ions with the
molecular formula CuII[C21H29N12O4]
+ and CuI[C21H30N12O4]
+,
which is in agreement with the formation of a 1 : 1 Cu–3H
complex. Also, the linear increase in absorption near 529 nm
supports occurrence of equimolar complexes in the range of
CuII equivalent from 0–1 (Fig. S2†).Table 2 EPR parameters for the pH-dependent Cu–3H species and Cu
Cu2+ CuH3L
gk (gz) 2.417 2.3010
gt (gx, gy) 2.0826 2.0569, 2.0726
ACuk (A
Cu
z ) 129 168
ACut (A
Cu
x , A
Cu
y ) 4 7, 8
aNk
c — 8 (2N)
aNt (a
N
x , a
N
y ) — 11, 9 (2N)
a [|A|] ¼ 104 cm1. b CuHL and CuL were considered with the same param
to line broadening).
This journal is © The Royal Society of Chemistry 2015The UV-Vis absorption maximum (Cu d–d transition) shis
from 670 nm (associated with CuH3L) to 538 and 532 nm
associated with the CuHL and CuL, respectively (Table 1). This
observation supports that in CuHL and CuL the metal ion is
bound by 4N equatorial donor sets.34 This is in agreement with
the EPR spectroscopy parameters which indicate 4 nitrogen
donors in the equatorial plane (Table 2 and Fig. 3). The log K
correlated to the change of CuHL to CuL is 5.28(2). This
observation as well as a shi in D3 near 311 nm in the CD
spectra suggest the involvement of an amide donor in the CuL
complex, in addition, the EPR and UV-Vis data indicate that
both species, CuHL and CuL have 4 nitrogen donor set with a
very similar ligand eld.
Based on the known Cu–peptide complex structures at pH
4.5–5.8 with linear5,6 and cyclic peptides35 it could be proposed
that in 3H at least eight nitrogen donors arranged in a three
dimensional net are available for CuII binding, including 5 and
6 member chelate forming sites (Fig. S1a†). This allows for
exchange of nitrogen donors as pH changes. In order to
understand the potential role of structural motifs in metal
binding the partial structural analogs to 3H were used in further
comparisons (Fig. S1b–d†).
The 2HG peptide (Fig. S1b†), which contains Gly instead the
C-terminal His residue of 3H, in the 4.5–5.5 pH range binds CuII
by its N-terminal fork.10 The UV-Vis (l/3 ¼ 620/100) and CD
(l/D3 ¼ 668/074, 321/0.41) spectroscopic parameters for 2HG
supported a 3N complex. The data for CuHL (L ¼ 3H) in the
same pH range are very diﬀerent and consistent with a 4N
environment (Tables 1 and 2). This diﬀerence excludes the
option of closely related metal coordination by 2HG and 3H in
this pH range (Fig. S1b†).
The H-HVH-OH peptide represents the backbone peptide
chain of 3H (Fig. S1c†). The spectroscopic parameters for the
corresponding CuII complexes with H-HVH-OH and 3H are also
incompatible. In case of H-HVH-OH at pH 4.5–5.5 two
complexes, CuHL and CuL (L¼H-HVH-OH) were observed. The
UV-Vis (l/3) parameters, 690/26 and 630/46, support 3N and 4N
complexes, respectively36 and are diﬀerent from those observed
for CuHL (L¼ 3H). The diﬀerence between the above listed data
negates the hypothesis that the N- and C-terminal backbone
arms of 3H (Fig. S1c†) are unaccompanied in the binding of CuII
in this pH region.
Finally, for 2GH, in which both N-terminals are Gly residues,
instead of the His residues for 3H (Fig. S1d†), the UV-VisIIa
“CuHL + CuL”b CuH1L CuH2L
2.1948 2.1865 2.1906
2.0407, 2.0544 2.0387, 2.0536 2.0407, 2.0511
193 198 196
9, 17 11, 21 14, 27
8 (4N) 8 (4N) 8 (4N)
11, 12 (4N) 14, 15 (4N) 11, 14 (4N)
eters. c Estimation from unresolved structures (the eﬀect is comparable
RSC Adv., 2015, 5, 56922–56931 | 56925
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View Article Onlineparameters, (l/3) 529/98, in the respective pH range were
assigned to CuH1L. In this complex the {NH2, 2N
, Nim} donor
set is expected.10 The diﬀerences in (l/3) 538/65 from CuHL (L ¼
3H) don't support hypothesis about exactly the same coordi-
nation mode, however, strong similarity is observed in the CD
spectra corresponding to CuL indicating the special role of theFig. 3 Experimental (red) and simulated (black) EPR spectra at
diﬀerent pH for the CuII : 3H system.
56926 | RSC Adv., 2015, 5, 56922–56931C-terminal arm (for 2GH the respective data are (l/D3)
568/0.58, 481/0.23, 305/1.28 and 270/2.05). This close
resemblance indicates structural similarities between Cu–2GH
and Cu–3H in this pH region.37
Based on the presented information we conclude that even
the presence of two N-terminal His arms in 3H peptide is
insuﬃcient to force out the C-terminal His from the coordina-
tion sphere of CuII. It follows that the C-terminal localization of
His is strongly desirable for CuII binding already at slightly
acidic pH.
As a summary, it can be proposed that all three arms should
participate in CuII coordination either by direct metal ligation
or by the support of a hydrogen bond network causing very little
spectroscopic diﬀerences between the CuHL and CuL.38,39
Formation of CuH1L (Fig. 2 pH 6–7) is accompanied by
moderate changes in UV-Vis, CD and also EPR spectroscopy
(Tables 1 and 2). The spectroscopic parameters are closely
related to the CuII complex with 2GH which occurs in this pH
range and in which the metal is bound by {NH2, 2N
, Nim}.10
This close similarity in the spectroscopic parameters indicates
that 3H at pH 7 binds the CuII with the involvement of the
C- and N-terminal main chain arms.
Interestingly, CuHL, CuL and CuH1L dominate in the pH
range 4.5–7 where the switching between the aﬃnity for CuII
binding was calculated based on the stability constants (Fig. 4)
and was also proved experimentally.10 Forming of these inter-
mediate forms with spectroscopic parameters between those
known for 2HG at low pH and 2GH at high pH is justied by
switching of CuII binding between the corresponding branched
peptide arms in 3H.
Further increase in pH up to 9 results in CuH2L (L ¼ 3H).
This process with log K ¼ 7.51(3) does not induce signicant
spectroscopic changes and could be rationalized by the depro-
tonation of the non-coordinated amino group at one of theFig. 4 Speciation diagram for CuII and 3H, dashed lines show curves of
competition for CuII between the ligands 2HG (red) and 2GH (blue).
The gray rectangle illustrates the region where the switching between
branches that participate in CuII binding takes place as the respective
complex species marked with green (CuHL, CuL and CuH1L) occur
(the conditions of speciation and competition diagram: [CuII] ¼ [3H] ¼
1  103 M, [CuII] ¼ [2GH] ¼ [2HG] ¼ 1  103 M respectively).
This journal is © The Royal Society of Chemistry 2015
Fig. 5 The (+) ESI-MS spectrum of the CuII–L mixture at pH 6.8: (a) the Cu2+ : L ratio was 0.4 : 1.0 and (b) the Cu2+ : L ratio was 0.7 : 1.0 (CL ¼
0.8  104 M, where L ¼ 3H). Respective, blown up regions of spectra are marked with red and blue.
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View Article OnlineN-terminal branches, but nowise with any major changes in the
rst coordination sphere CuH2L.Fig. 6 Competition plot showing the distribution of CuII between
2GH, 2HG and 3H as a function of pH, [CuII] ¼ [2GH]¼ [2HG]¼ [3H] ¼
1  103 M. Partitions denote those pH regions where spectroscopic
parameters of 3H could be recognized as: (a) similar to 2HG (red), (b)
3H speciﬁc (2HG and 2GH competitive region), (c) similar to 2HG
(blue).Competition study between Dap-based peptides
Fig. 6 shows the distribution of CuII among 2GH, 2HG and 3H,
present in equal concentration. First of all, the CuII distribution
switches between 2HG and 2GH (Fig. 6a and c) near pH 6. Up to
pH 5 2HG, while above pH 7 the 2GH is the predominant ligand.
Between pH 5 and 7 both peptides were found to be competitive
(Fig. 6b).10 Somewhat surprisingly 3H is by far the best CuII
complexing agent in the whole pH range, leaving behind both
its N- (2HG) and C-terminal (2GH) domains (Fig. 1, S1b and d†).
The coordination prole observed in case of 3H in the pH range
up to 3.5 can be recognized as similar to 2HG (Fig. 1a), above pH
7 as similar to 2GH (Fig. 1b). In the region between 3.5 and 7 the
involvement of all three branches in complexation of CuII is
proposed. The observed extra stabilization may be rationalized
by means of hydrogen bond network, similar to those observed
for long, linear multi-histidine tags and histidine rich
proteins.38,39This journal is © The Royal Society of Chemistry 2015 RSC Adv., 2015, 5, 56922–56931 | 56927
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The cyclic voltammograms (CVs) of the Cu–3H system were
recorded at pH 7 and 8 (Fig. 7). This pH region is common
condition for many of the enzymatic processes and biological
environments. Under the given conditions 3H has high aﬃnity
for CuII (Fig. 6), but the question of redox stability remains
open. Cathodic polarization of the GC working electrode yields
a Faradaic current peak that shis to more negative potential by
40 mV with increasing pH to 8 (E0pc1). On the reverse direction
the anodic current peak occurs at considerably higher potential
(E0pa1) that is clear indication of a rapid background chemical
process (electrochemical–chemical–electrochemical, ECE
mechanism).
Such behavior is oen observed for CuII/I transitions as the
change in the redox state induces fundamental changes in the
coordination number and geometry.40 In the pH range of 6–8,
Cu–3H complexes are present in three protonation states: CuIIL,
(and predominantly) CuIIH1L and Cu
IIH2L (Fig. 2). The pH-
dependent spectroscopic features indicate (vide supra) that the
coordination sphere – involving all three arms and consisting of
3 neutral N donor groups beside one N – transforms to {NH2,
2N, Nim} upon deprotonation of Cu
IIL. Hureau et al. compared
the redox features of [CuII(GHK)] (with 1Nim), [Cu
II(GHK)2] (with
2Nim) and [Cu
II(GHK)(His)] (with 2Nim) (GHK ¼ H-Gly-His-Lys-
OH) at pH ¼ 7.4 and suggested that addition of Nim will
prevent losing the metal upon reduction,41 which otherwise
leads to metallic copper deposition at the electrode. As a char-
acteristic feature in CV they observed in the anodic direction a
Cu0 to CuI oxidation-solubilization current peak beside the CuI
to CuII peak.
All this information led us to propose a mechanism (Scheme
1) for the observed CuII/I redox cycle of the Cu–3H system.
According to this mechanism, the irreversible, pH-dependentFig. 7 Cyclic voltammograms of the Cu–3H system (2 mM in water,
0.1 M NaClO4, under argon at 25 C) at pH 7.0 (bottom) and at pH 8.0
(top) plotted on the same scale. The initial potential is 0.6 V for scans to
both the anodic and cathodic directions (see blue and brown
arrowheads).
56928 | RSC Adv., 2015, 5, 56922–56931E0pc1 can be assigned as the Cu
IIH1L to Cu
IL proton coupled
electron transfer (PCET) reaction, while the E0pa1 to the Cu
IL to
CuIIL oxidation. The driving force of this mechanism is the
possibility of intra-ligand translocation of copper upon reduc-
tion, allowed by the branched structure of 3H. Once in the CuL
form, the changed donor set will accommodate both CuI and
CuII. One may suppose as an alternative assignment for E0pc1-
that CuIIH1L is reduced directly to Cu
IH1L. This species
would most likely release CuI, or may again translocate CuI to
the available His arms. The presence of free CuI would lead to
oxidation-solubilization current peak, but this is not observed
in the presented voltammograms. Therefore we suggest that, if
free CuI is produced at all, it will be rapidly re-complexed by the
neutral free ligand according to Scheme 1. The Cu–3H system
exhibits a quasi-reversible CuIII/II redox transition at pH 6.98
(Fig. 7, E0pa2 and E0pc2) with E1/2 of  0.88 V vs. Ag/AgCl, DEp 
100 mV and approximating Ia ¼ Ic at 200 mV s1. Chro-
noamperometry indicates that the current peaks associated
with the CuII/I and CuIII/II processes involve equal number of
electrons (Fig. S3†). The E1/2 value in comparison with literature
examples where the equatorial binding plane of the complex is
reported,1,40–42 suggests a {NH2, 2N
, Nim} donor plane that is
exactly what spectroscopic results indicate for CuIIH1L
and CuIIH2L. However, when the pH is shied to 8, even at
400 mV s1, Ia considerably exceeds Ic, showing that an ECrev
mechanism is operating accelerated by basic pH and competing
with the electrochemical reduction of CuIII on the CV timescale.
A decrease in the peak potentials of30mV could be estimated.
To our knowledge, information on the pH-dependence of
CuIII/II transitions in Cu-peptide complexes is rare in litera-
ture,23,43 despite that proton transfer processes coupled to redox
transitions (PCET) are of key importance in biochemistry and
catalysis.44 Therefore we aimed to determine the CuIII/II poten-
tial in the pH range from 7 to 8.8 for the Cu–3H system. In this
range the CuIIH1L and Cu
IIH2L forms are predominant.
Instead of CV we applied square-wave voltammetry (SWV) to
determine the E0 values accurately, upon shiing the pH by
small increments.1 The Enet (potential of Inet) vs. pH plots will
directly give Pourbaix diagrams, when reversibility terms of theScheme 1 Proposed processes that contribute to the observed CuII/I
redox transitions in the CVs.
This journal is © The Royal Society of Chemistry 2015
Fig. 8 (a) CuIII/II net potentials (Enet) determined by square-wave voltammetry (SWV) and plotted as a function of pH. The solid line represents a
nonlinear regression curve ﬁt to eqn (2) (R2 ¼ 0.9857, for parameters see Table 3). (b) Baseline corrected net current SW voltammograms of the
Cu–3H system between pH 7.04 and 8.79. The potentials in Fig. 7a correspond to Enet of the baseline corrected net current traces, Inet¼ Ifor Irev,
where forward means the current response to the oxidation pulse while reverse to the reduction pulse. (c) Plot of the ratio of Ifor and Irev
components as a function of pH. SWV conditions: 0.7 mM Cu–3H, 100 mM NaClO4, temperature 25.0  0.1 C, tp ¼ 10 ms (f ¼ 50 Hz), step
potential 0.2 mV, SW pulse amplitude 25 mV, 0.072 cm2 GC working electrode, 2 cm2 Pt auxiliary electrode and Ag/AgCl (3 M KCl) reference
electrode. All experiments were conducted under an Ar blanketing atmosphere, where O2 concentration was <2 mM.
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View Article Onlineelectrode process are fullled. Fig. 8 summarizes the SWV
results for the CuIII/II transition (Table S1 sums the data,
Fig. S4† illustrates reproducibility). In Fig. 8a the Enet data
points are plotted against the pH generating a Pourbaix
diagram for the CuIII/II process. Note that the Ifor/Irev ratio
approximating 1 (Fig. 8c) and symmetrical current peaks are
landmarks of reversibility on the timescale of the experiment.
Presuming that eqn (1) describes the electrochemical process, a
modied Nernst eqn (2) can be written to explain the pH-
dependence of Enet.45 In this equation we presume the involve-
ment of both the reduced (CuII) and oxidized (CuIII) form in one
protic equilibrium:
CuIIIH2L + e
# CuIIH2L (1)
Enet ¼ E0

CuIIIH2L

CuIIH2L; pH ¼ 0

þ 0:0591 log KaðredÞ þ ½H
þ
KaðredÞKaðoxÞ þ KaðredÞ½Hþ  0:0591pH
(2)
where Ka(red) is the acid dissociation constant of Cu
IIH1L to
CuIIH2L, Ka(ox) is the acid dissociation constant of Cu
IIIH2L toTable 3 Formal potential and pKa values derived from the ﬁt of eqn (2)
to experimental Enet vs. pH data for the Cu
III/II redox transition
Eqn (2)
pKa(red) 7.3(1)
E0 (CuIIIH2L/CuIIH2L) vs. Ag/AgCl(V) 0.831(3)
pKa(ox) 8.7(1)
This journal is © The Royal Society of Chemistry 2015CuIIIH3L and E0 (Cu
IIIH2L/Cu
IIH2L, pH ¼ 0) is the formal
potential of the process in eqn (1). Fit of eqn (2) to Enet data points
yields the line in Fig. 8a and parameters as listed in Table 3.
The pKa(red) is in satisfactory agreement with the log K ¼
7.51(3) value for the CuIIH1L form derived from potentiometry.
The projections of the tted function to pH ¼ 0 (e.g.,
E0(CuIIIH2L/Cu
IIH2L, pH ¼ 0) + 0.0591pKa(red or ox)) give
E0(CuIIIH2L, H
+/CuIIH1L, pH¼ 0) as 1.26 V and E0(CuIIIH3L,
H+/CuIIH2L, pH ¼ 0) as 1.34 V. These potentials along with theScheme 2 Processes operating in the pH range of the SWV study.
RSC Adv., 2015, 5, 56922–56931 | 56929
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View Article Onlinet parameters can be assigned to equilibria, which are arranged
into a stepladder scheme of the PCET processes (Scheme 2,
protons and electrons are omitted for sake of simplicity).
The horizontal equilibria involve no change in protons (ET),
while vertical ones no change in electrons (PT). The diagonal
processes are assigned as multiple site electron-proton transfer
(MS-EPT44) processes, diﬀering in their potential by
0.0591pKa(red or ox) from the value for the ET of 0.83 V.
According to this scheme, the MS-EPT processes become
favored for the Cu–3H system at pH below pKa(red) and above
pKa(ox).Conclusions
Our strategy to combine in one three dimensional branched
peptide two structural motifs with maximal CuII binding eﬃ-
ciency in diﬀerent ranges of pH, resulted in the design of the
novel triple-arm peptide 3H. Our data demonstrate that this
structure can signicantly increase CuII binding aﬃnity. The
extra stabilization of Cu–3H complexes in comparison with
analogues of the CuII binding domains indicate that all arms are
involved in metal binding near the physiological pH, moreover,
the C-terminal His residue is dominating.
Prolongation of the C-terminal peptide arm therefore can be
recommended in order to functionalize the complex with, for
example, anchoring moiety or peptide sequence targeting.
Importantly, upon reduction of CuII to CuI bound to 3H no
metal deposition was observed at the electrode, indicating that
the ligand can retain CuI from dissociation. We attribute this
behavior to the propensity of 3H to exibly adopt its structure to
altered redox conditions. This advantage of 3H is also traced in
supporting a CuIII/II redox transition among the very same
conditions, separated by 1.2 V from the CuII to CuI reduction.
Our electrochemical investigations suggest that PCET processes
play key role in redox-coupled structure switching. Surface
anchoring of our complexes will be explored in upcoming
studies.
This experience can be applied in the design of CuII-peptide
based radiopharmaceuticals, metal sensors, peptide based CuII
uoroprobes and also applied in the catalytic/electocatalytic
multi histidine metallopeptides or articial proteins. The pre-
sented Dap peptide frame and branching methodology may
help achieve the desirable goal of elucidating the contribution
of diﬀerent aminoacids (donor groups) localized in diﬀerent
positions of three dimensional net to understand their role in
copper biding and activity.Acknowledgements
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